Co-production and evaluation of an e-learning resource to improve African Caribbean families’ knowledge about schizophrenia and engagement with services
| ISRCTN | ISRCTN11394005 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN11394005 |
| Secondary identifying numbers | 37800 |
- Submission date
- 19/03/2018
- Registration date
- 20/03/2018
- Last edited
- 29/11/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
Schizophrenia is a severe long-term mental health condition where the person may not always be able to distinguish their own thoughts and ideas from reality. Improving family members’ attitudes and knowledge about schizophrenia has been shown to reduce family tensions and hostility and create more sympathetic home environments, which in turn reduces the risk of relapse and rehospitalisation. Stigmatising attitudes towards persons with mental illness in the wider community have been reported to negatively affect service users’ outcomes. NICE guidance suggests family-focused interventions for African Caribbean families with schizophrenia are urgently needed. As there are currently no culturally-appropriate, psychological education resources for this group, the aim of this study is to work with families and service users to develop and test such a resource in this ethnic group.
Who can participate?
People aged 16 and over with a relative of Black Caribbean heritage (including ‘Black British’ and ‘Mixed’ heritage) with schizophrenia or other non-affective psychosis
What does the study involve?
Participants are randomly allocated to one of two groups. Participants in the treatment group complete assessments of their knowledge about psychosis, attitudes towards mental illness and their subjective health. They are then given access to the e-learning resource, and asked to explore the resource on their pace with no minimum requirements for how often or how much at once they should use the resource. After 2 weeks, participants are asked to complete the same assessments and attend an interview. Finally, participants are invited to complete the assessments after 3 months. Participants in the control group are also tested at the same times but do not receive the intervention until after data collection has ended.
What are the possible benefits and risks of participating?
The researchers cannot promise that the study will help the participants directly but they are doing this research because they believe that the programme will help to improve care and support for African Caribbean patients with schizophrenia and their families. They believe that improving carers and families’ knowledge and awareness of schizophrenia and understanding of health professional roles will improve relationships within families. Collecting information on knowledge about schizophrenia/other psychoses and quality of life will enable them to choose the best ways of measuring the impact of the programme in future studies. Ultimately, they hope that this programme will reduce family stress and tension, which should improve outcomes for patients. Thinking and learning more about mental illness and mental health services might be upsetting for some people. Participants can stop at any point if they feel upset. If they feel distressed whilst using the programme they can contact the lead researcher, Dr Dawn Edge, at the University on 0161 275 2570. The researchers also provide a list of organisations that are able to provide support to all participants and help them to get support if they wish.
Where is the study run from?
1. The University of Manchester (UK)
2. Manchester Royal Infirmary (UK)
When is the study starting and how long is it expected to run for?
May 2015 to August 2018
Who is funding the study?
National Institute for Health Research (NIHR) (UK)
Who is the main contact?
Dr Dawn Edge
Contact information
Scientific
Coupland 1 building
The University of Manchester
Oxford Road
Manchester
M13 9PL
United Kingdom
 ORCID ID |
0000-0003-1139-6613 |
|---|
Study information
| Study design | Randomised; Interventional; Design type: Treatment, Education or Self-Management |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Treatment |
| Participant information sheet | ISRCTN11394005_PIS_14Sep17_V3.docx |
| Scientific title | Co-production and evaluation of an e-learning resource to improve African Caribbean families’ knowledge about schizophrenia and engagement with services |
| Study acronym | Casper |
| Study objectives | Improving family members’ attitudes and knowledge about schizophrenia has been shown to reduce family tensions and hostility thus creating more sympathetic home environments, which in turn reduces risk of relapse and rehospitalisation. Stigmatising attitudes towards persons with mental illness in the wider community has been reported to negatively affect service users’ outcomes. NICE guidance suggests family-focused interventions for African Caribbean families with schizophrenia are urgently needed. As there are currently no culturally-appropriate, psychological education resources for this group, we plan to work with families and service users to develop and test such a resource in this ethnic group. |
| Ethics approval(s) | London - City & East Research Ethics Committee, 03/06/2015, ref: 15/LO/0896 |
| Health condition(s) or problem(s) studied | Specialty: Mental health, Primary sub-specialty: Psychosis - schizophrenia; UKCRC code/ Disease: Mental Health/ Schizophrenia, schizotypal and delusional disorders |
| Intervention | Participants are randomised using sealedenvelope.com. Participants in the treatment group will complete baseline measures assessing their knowledge about psychosis, attitudes towards mental illness and their subjective health. After the baseline data collection, participants will be given access to the e-learning resource, and asked to explore the resource on their pace with no minimum requirements for how often or how much at once they should use the resource. After 2 weeks (duration of treatment) of gaining access to the resource, participants will be asked to complete the same measures and attend an interview. Finally, participants will be invited to complete the measures after 3 months (follow up time). The control group will also be tested at the same timepoints but will not receive the intervention until after research data collection has ended. |
| Intervention type | Other |
| Primary outcome measure | 1. Knowledge about psychosis is measured using the Culturally-Adapted Knowledge About Psychosis Questionnaire at baseline, 2 weeks and 3 months 2. Attitudes towards mental illness are measured with the Anxiety Surrounding Mental Illness Scale at baseline, 2 weeks and 3 months |
| Secondary outcome measures | 1. Acceptability of the intervention is measured with an interview comprising questions about participants’ experiences of using the intervention 2. Participants’ health is measured with the SF-12 Health Survey v2 at baseline, 2 weeks and 3 months |
| Overall study start date | 05/05/2015 |
| Completion date | 31/08/2018 |
Eligibility
| Participant type(s) | Carer |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | Planned Sample Size: 40; UK Sample Size: 40 |
| Key inclusion criteria | 1. Must have a relative of Black Caribbean heritage (including ‘Black British’ and ‘Mixed’ heritage) with a diagnosis of schizophrenia or other non-affective psychosis 2. Minimum age 16, no upper age limit 3. Sufficient English skills to access the intervention and complete the measures |
| Key exclusion criteria | 1. Persons without a relative of Black Caribbean heritage with a schizophrenia/non-affective psychosis diagnosis 2. Health professionals 3. Under 16s |
| Date of first enrolment | 01/09/2017 |
| Date of final enrolment | 30/06/2018 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centres
Oxford Road
Manchester
M13 9PL
United Kingdom
Oxford Road
Manchester
M13 9WL
United Kingdom
Sponsor information
Hospital/treatment centre
c/o Lynne Macrae
Room 1.21A Simon Building
Oxford Road
Manchester
M13 9PL
England
United Kingdom
"ROR" |
https://ror.org/027m9bs27 |
|---|
Funders
Funder type
Government
No information available
Results and Publications
| Intention to publish date | 31/08/2019 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Data sharing statement to be made available at a later date |
| Publication and dissemination plan | The trialists are planning to publish in high-impact peer-reviewed journals around 31/08/2019 |
| IPD sharing plan | The data sharing plans for the current study are unknown and will be made available at a later date |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | version V3 | 14/09/2017 | 20/03/2018 | No | Yes |
| Protocol file | version V3 | 14/09/2017 | 20/03/2018 | No | No |
| Protocol article | protocol | 20/11/2018 | Yes | No | |
| HRA research summary | 28/06/2023 | No | No |
Additional files
- ISRCTN11394005_PIS_14Sep17_V3.docx
- Uploaded 20/03/2018
- ISRCTN11394005_PROTOCOL_14Sep17_V3.docx
- Uploaded 20/03/2018
Editorial Notes
29/11/2018: Publication reference added.
20/03/2018: Uploaded protocol Version 3, 14 September 2017 (not peer-reviewed).
